Recombinant immunotoxin anti-c-Met/PE38KDEL inhibits proliferation and promotes apoptosis of gastric cancer cells

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Wei, Xu ^a   Juan, Zhu Xiao ^a   Min, Feng Xiao ^b   Nan, Cai ^a   Hua, Zhang Xiu ^a   Qing, Feng Zheng ^b   Zheng, Liu ^a  

^a THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; IMMUNOTOXIN; LEUCINE; RECOMBINANT IMMUNOTOXIN C MET ANTIBODY; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG; EXOTOXIN; IMMUNOGLOBULIN FRAGMENT;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL COUNT; CELL PROLIFERATION; COLORIMETRY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; FLOW CYTOMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; STOMACH CANCER; WESTERN BLOTTING; BIOSYNTHESIS; CELL GROWTH; DRUG EFFECT; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

APOPTOSIS; CASPASE 3; CELL GROWTH PROCESSES; CELL LINE, TUMOR; EXOTOXINS; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOTOXINS; PROTO-ONCOGENE PROTEINS C-MET; STOMACH NEOPLASMS;

EID: 79959924567     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-67     Document Type: Article

References (31)

1. Can gastric cancer be prevented? B Tepes, J Physiol Pharmacol 2009 60 71 77
2. Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial. M Gubanski A Johnsson E Fernebro L Kadar I Karlberg P Flygare A Berglund B Glimelius PA Lind, Gastric Cancer 2010 13 155 161
3. Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition. S Corso E Ghiso V Cepero JR Sierra C Migliore A Bertotti L Trusolino PM Comoglio S Giordano, Mol Cancer 2010 9 121
4. Cancer-stromal interaction through growth factor/cytokine networks implicated in growth of stomach cancer. E Tahara, Princess Takamatsu Symp 1994 24 187 194
5. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. DP Bottaro JS Rubin DL Faletto AM Chan TE Kmiecik GF Vande Woude SA Aaronson, Science 1991 251 802 804 (Pubitemid 21926175)
6. The overexpression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation. U Drebber SE Baldus B Nolden G Grass E Bollschweiler HP Dienes AH Hölscher SP Mönig, Oncol Rep 2008 19 1477 1483
7. Correlation of hepatocyte growth factor-induced proliferation and calcium-activated potassium current in human gastric cancer cells. SI Liu CW Chi WY Lui KT Mok CW Wu SN Wu, Biochim Biophys Acta 1998 1368 256 266
8. Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies. RJ Kreitman, BioDrugs 2009 23 1 13
9. Antitumor activity of fibroblast growth factor receptor 3-specific immunotoxins in a xenograft mouse model of bladder carcinoma is mediated by apoptosis. JL Martínez-Torrecuadrada LH Cheung P Lápez-Serra R Barderas M Cãamero S Ferreiro MG Rosenblum JI Casal, Mol Cancer Ther 2008 7 862 873 (Pubitemid 351551039)
10. Construction, expression and purification of an immunotoxin containing a human anti-c-Met single-chain antibody fused to PE38KDEL. XJ Zhu ZQ Feng J Zhu qi Tang zheng Liu, Acta Univ Med Nanjing 2009 29 920 924
11. PPARgamma inhibits the expression of c-MET in human gastric cancer cells through the suppression of Ets. S Kitamura Y Miyazaki S Hiraoka M Toyota Y Nagasawa S Kondo T Kiyohara Y Shinomura Y Matsuzawa, Biochem Biophys Res Commun 1999 265 453 456
12. Participation of c-met in the progression of human gastric cancers: anti-c-met oligonucleotides inhibit proliferation or invasiveness of gastric cancer cells. M Kaji Y Yonemura S Harada X Liu I Terada H Yamamoto, Cancer Gene Ther 1996 3 393 404 (Pubitemid 126732461)
13. Study of APC, Rb, c-met gene copy numbers of human gastric mucosa epithelial cell line GES-1. S Zheng Y Ke, Zhonghua Zhong Liu Za Zhi 1999 21 409 411
14. Histone deacetylase inhibitors and 15-deoxy-Delta12,14-prostaglandin J2 synergistically induce apoptosis. M Koyama Y Izutani AE Goda TA Matsui M Horinaka M Tomosugi J Fujiwara Y Nakamura M Wakada S Yogosawa Y Sowa T Sakai, Clin Cancer Res 2010 16 2320 2332
15. The melanoma specific 9.2.27PE immunotoxin efficiently kills melanoma cells in vitro. K Risberg Fodstad Y Andersson, Int J Cancer 2009 125 23 33
16. Downregulation of the antiapoptotic MCL-1 protein and apoptosis in MA-11 breast cancer cells induced by an anti-epidermal growth factor receptor-Pseudomonas exotoxin a immunotoxin. Y Andersson S Juell Fodstad, Int J Cancer 2004 112 475 483 (Pubitemid 39390614)
17. Genistein induces G2/M cell cycle arrest via stable activation of ERK1/2 pathway in MDA-MB-231 breast cancer cells. Z Li J Li B Mo C Hu H Liu H Qi X Wang J Xu, Cell Biol Toxicol 2008 24 401 409
18. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. T Yamashima, Prog Neurobiol 2000 62 273 295 (Pubitemid 30326777)
19. Caspases: the executioners of apoptosis. GM Cohen, Biochem J 1997 326 1 16 (Pubitemid 27386911)
20. Advances in the pharmacological treatment of gastro-oesophageal cancer. AD Wagner U Wedding, Drugs Aging 2009 26 627 646
21. Gastric cancer cell line Hs746T harbors a splice site mutation of c-Met causing juxtamembrane domain deletion. Y Asaoka M Tada T Ikenoue M Seto M Imai K Miyabayashi K Yamamoto S Yamamoto Y Kudo D Mohri Y Isomura H Ijichi K Tateishi F Kanai S Ogawa M Omata K Koike, Biochem Biophys Res Commun 2010 394 1042 1046
22. Expression of c-erbB-2 and c-met proteins in gastric adenoma and adenocarcinoma. SW Lee SB Kang YS Kim SW Nam DS Lee HK Lee SW Han, Korean J Gastroenterol 2007 49 152 157
23. Cellular prion protein promotes invasion and metastasis of gastric cancer. Y Pan L Zhao J Liang J Liu Y Shi N Liu G Zhang H Jin J Gao H Xie J Wang Z Liu D Fan, FASEB J 2006 20 1886 1888
24. Karyotypic analysis of gastric carcinoma cell lines carrying an amplified c-met oncogene. G Rege-Cambrin P Scaravaglio F Carozzi S Giordano C Ponzetto PM Comoglio G Saglio, Cancer Genet Cytogenet 1992 64 170 173 (Pubitemid 23044958)
25. c-Met expression in gastric cancer with liver metastasis. H Amemiya K Kono J Itakura RF Tang A Takahashi FQ An S Kamei H Iizuka H Fujii Y Matsumoto, Oncology 2002 63 286 296 (Pubitemid 36151324)
26. Experimental study of the hepatocyte growth factor contributing to lymphangiogenesis and lymphatic metastasis in gastric cancer. QH Zhang K Qian XJ Li J Pu XT Wu, Zhonghua Wei Chang Wai Ke Za Zhi 2007 10 212 216
27. The conjugate Rituximab/saporin-S6 completely inhibits clonogenic growth of CD20-expressing cells and produces a synergistic toxic effect with Fludarabine. L Polito A Bolognesi PL Tazzari V Farini C Lubelli PL Zinzani F Ricci F Stirpe, Leukemia 2004 18 1215 1222 (Pubitemid 39023131)
28. Mutational analysis of caspase genes in prostate carcinomas. MS Kim SW Park YR Kim JY Lee HW Lim SY Song NJ Yoo SH Lee, APMIS 2010 118 308 312
29. Anti-cancer activity of anti-p185HER-2 ricin A chain immunotoxin on gastric cancer cells. XX Zhou F Ji JL Zhao LF Cheng CF Xu, J Gastroenterol Hepatol 2010 25 1266 1275
30. RGD-FasL induces apoptosis of pituitary adenoma cells. L Chen G Zhuang W Li Y Liu J Zhang X Tian, Cell Mol Immunol 2008 5 61 68
31. Human ICE/CED-3 protease nomenclature. ES Alnemri DJ Livingston DW Nicholson G Salvesen NA Thornberry WW Wong J Yuan, Cell 1996 87 171